Picture EBD Group Biotech Showcase 2024 San Francisco 650x100px
Organisation › Details

SCOPE Consortium (SCreening fOr Pregnancy Endpoints)

About SCOPE Consortium: The SCOPE study arises from the knowledge that there are a number of potential clinical and molecular markers (certain proteins, fats and small molecules in blood) for these complications. None of these candidate markers are useful as individual predictive tests, but combinations of markers are likely to result in clinically useful screening tests. Further, recent advances in proteomic and metabolomic technologies and bioinformatics (advanced mathematics) allow us to discover and map differences in molecules circulating in the blood of women who later develop these conditions. This has created the opportunity to develop effective methods of predicting these diseases, with the potential to dramatically improve maternal and infant health worldwide. *


Period Start 2012-07-09 existent
Products Industry prenatal test
  Industry 2 women’s health
  City n. a. 
    Address record changed: 2012-08-28
Basic data Employees n. a.
    * Document for »About Section«: 
Record changed: 2023-07-10


Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group Biotech Showcase 2024 San Francisco 650x300px

» top